Troy A. Ignelzi

Chief Financial Officer & Secretary at Karuna Therapeutics, Inc.

Troy A. Ignelzi

Troy A. Ignelzi

Chief Financial Officer & Secretary at Karuna Therapeutics, Inc.

Overview
Career Highlights

Karuna Therapeutics, Inc.
Juventas Therapeutics, Inc.
scPharmaceuticals, Inc.

RelSci Relationships

192

Number of Boards

1

Birthday

1968

Age

52

Contact Data
Trying to get in touch with Troy A. Ignelzi? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Troy A. Ignelzi likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Vedanta Biosciences, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Vedanta Biosciences, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Vedanta Biosciences, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Vedanta Biosciences, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Vedanta Biosciences, Inc.

Relationship likelihood: Strong

Co-Founder at Vedanta Biosciences, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer, Chief Financial Officer & Director at scPharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder at Juventas Therapeutics, Inc.

Relationship likelihood: Strong

Chief Accounting Officer & Senior Vice President-Finance at scPharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Strategy Officer at Juventas Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Troy A. Ignelzi
Potential Connections via
Relationship Science
You
Troy A. Ignelzi
Chief Financial Officer & Secretary at Karuna Therapeutics, Inc.
Education
BS Accounting

Ferris State University is an American public university with its main campus in Big Rapids,

Career History
Chief Financial Officer & Secretary
2019 - Current

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.The company was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.

Chief Financial Officer
2014 - 2016

Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH.

Vice President-Business Development & Strategic Planning
2007 - 2009

InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ.

Transactions
Details Hidden

scPharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

scPharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

scPharmaceuticals, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Troy A. Ignelzi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Troy A. Ignelzi's profile does not indicate a business or promotional relationship of any kind between RelSci and Troy A. Ignelzi.